Fatigue
harm-reductionA sustained sense of depleted physical or mental capacity that rest does not immediately resolve, distinct from ordinary sleepiness. In drug contexts it appears both as an after-effect once a substance clears and as a feature of withdrawal.
Fatigue in drug contexts is a sustained sense of depleted physical or mental capacity that rest does not immediately resolve — distinct from ordinary sedation, which a single night's sleep typically clears. It appears both as an after-effect once a substance clears the body and as a feature of withdrawal.
Stimulants produce it most visibly: the wakefulness they force borrows from the body's reserves, and once the drug clears, the deferred tiredness surfaces. Disrupted sleep, dehydration, and altered neurochemistry each contribute. Serotonergic substances are associated with a particular cognitive fatigue in the days following use — often described as a heaviness or emotional flatness. Sedatives and opioids leave fatigue in their wake through changes to sleep architecture.
How it is done
Recognising fatigue as substance-related rather than incidental matters because the common response is to redose — particularly with stimulants — which can extend the wakefulness window and deepen the subsequent crash. Understanding it as a predictable consequence, rather than a problem more of the same substance can solve, is the harm-reduction framing.
Recovery generally follows the same broad principles as ordinary fatigue: sleep, hydration, nutrition, and time. The timeline varies by substance class and degree of use. Stimulant crashes typically resolve over hours to a day; serotonergic fatigue may persist several days. When fatigue is part of withdrawal, it tends to be more pronounced and longer-lasting, reflecting the body's adjustment to the absence of the substance.
What it cannot tell you
Fatigue alone cannot indicate whether a person is experiencing an ordinary come-down or something more serious. The sensation is not calibrated to the severity of the underlying state — someone in the early stages of withdrawal may feel tired but otherwise functional, while the same fatigue can also be the leading edge of a more difficult discontinuation process.
It cannot establish whether rest has been sufficient. A person may feel subjectively improved after sleep without their neurochemistry or sleep architecture having returned to baseline. Returning to use — or to full activity — before genuine recovery has occurred is one of the ways a single episode of heavy use extends into a pattern.
Fatigue does not identify its cause. Cumulative sleep debt, poor nutrition, and underlying medical conditions can all present identically. When fatigue is severe, prolonged, or accompanied by other symptoms, treating it as purely substance-related can lead to missing something else.
AI-generated · not yet verified by a human reviewer
Harm-reduction reference — not medical advice.